MedPath

Comparison of two different concentrations of Ropivacaine local anaesthetic for postoperative pain relief in abdominal hysterectomy surgeries

Phase 3
Conditions
Health Condition 1: N926- Irregular menstruation, unspecified
Registration Number
CTRI/2024/05/067730
Lead Sponsor
Priyadharshini S
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1.Elective surgeries with ASA Grading 1,2 and 3

2.Patients undergoing abdominal hysterectomy

3.Weight from 50kg to 80kg

4.Height from 145cm to 165cm

Exclusion Criteria

1.Patient refusal

2.Allergic to Ropivacaine and Fentanyl

3.Local infection at the site of epidural injection

4.Coagulopathy

5.Hypovolemia

6.Patient on anticoagulant therapy

7.Uncooperative patients

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To compare the VAS score at rest, movement and while coughing between the patients getting 0.1% and 0.2% ropivacaine as epidural infusion for pain reliefTimepoint: The time duration taken by the patient to complain of pain with VAS more than 3
Secondary Outcome Measures
NameTimeMethod
To compare haemodynamic changesTimepoint: The time duration taken for mean arterial pressure to fall less than 60;To compare the motor blockadeTimepoint: The time duration taken by the patient to complain of lower limb numbness;To compare the need for rescue analgesiaTimepoint: The time duration taken by the patient to complain pain with VAS more than 5 even after giving rescue analgesia
© Copyright 2025. All Rights Reserved by MedPath